Joel Sendek, an investment analyst, has been appointed chief financial officer at Forward Pharma A/S, a biopharmaceutical company working on new formulations for the chemical compound dimethyl fumarate. Mr Sendek joins the Denmark-based company from Stifel Financial Corp where he led the firm’s healthcare equity research group. He also spent 12 years with Lazard Capital Markets and was an investment banking analyst at Goldman Sachs. Mr Sendek holds a BA in biochemistry from Rice University in the US.
Forward Pharma announced the appointment on 11 August 2014.
Copyright 2014 Evernow Publishing Ltd